In terms of funding, because I believe we will be seeing the estimates soon, upcoming in a meeting shortly, how much was spent by the federal drug plans in reviewing new drugs prior to the creation of the CDR? In particular, where does the federal funding actually come from, and where will it appear in the estimate documents?
On April 23rd, 2007. See this statement in context.